Refine Your Results

Click below to filter your search results

Search Results

Return to List
Results 201–220 of 229
Title Date
201.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT Tamoxifen a nonsteroidal antiestrogen agent is widely used as adjunctive therapy for women with breast cancer and it has been approved by the US Food and Drug Administration for adjuvant treatment of breast cancer treatment of metastatic breast cancer and reduction in breast cancer incide...

June 2014

PDF Format
202.

The Apgar Score

Number 644

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format
203.

The Importance of Preconception Care in the Continuum of Women's Health Care

Number 313

(Reaffirmed 2015)

ABSTRACT The goal of preconception care is to reduce the risk of adverse health effects for the woman fetus or neonate by optimizing the womans health and knowledge before planning and conceiving a pregnancy Because reproductive capacity spans almost four decades for most women optimizing womens h...

September 2005

PDF Format
204.

The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist

Number 639

ABSTRACT Information from vital records is critical to identify and quantify healthrelated issues and to measure progress toward quality improvement and public health goals In particular maternal and infant mortality serve as important indicators of the nations health thereby influencing policy de...

September 2015

PDF Format
205.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

ABSTRACT The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years The initial reproductive health visit provides an excellent opportunity for the obstetriciangynecologist to start a pa...

May 2014

PDF Format
206.

The Limits of Conscientious Refusal in Reproductive Medicine

Number 385

Reaffirmed 2016

ABSTRACT Health care providers occasionally may find that providing indicated even standard care would present for them a personal moral problema conflict of conscienceparticularly in the field of reproductive medicine Although respect for conscience is important conscientious refusals should be l...

November 2007

PDF Format
207.

The Obstetric and Gynecologic Hospitalist

Number 657

(Replaces Committee Opinion Number 459, July 2010)

ABSTRACT The term hospitalist refers to physicians whose primary professional focus is the general medical care of hospitalized patients Their activities may include patient care teaching research and inpatient leadership The American College of Obstetricians and Gynecologists supports the continu...

February 2016

PDF Format
208.

The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Number 477

(Replaces No. 280, December 2002)

ABSTRACT Epithelial ovarian cancer is most commonly detected in an advanced stage when the overall 5year survival rate is 2030 Detection of earlystage ovarian cancer results in improved survival Currently there is no effective strategy for ovarian cancer screening Women with persistent and progres...

March 2011

PDF Format
209.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Number 440

(Reaffirmed 2015)

ABSTRACT The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography this initial evaluation does not require p...

August 2009

PDF Format
210.

The Transition From Pediatric to Adult Health Care: Preventive Care for Young Women Aged 18-26 Years

Number 626

ABSTRACT Young women aged 1826 years are a heterogeneous population transitioning from adolescence into adulthood who may present with unique issues and challenges including a potential gap in health care after pediatric health care Obstetriciangynecologists should note that these patients may nee...

March 2015

PDF Format
211.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Number 581

(Replaces No. 446, November 2009. Reaffirmed 2015)
(See also Practice Bulletin No. 88)

ABSTRACT Chromosomal microarray analysis is a technique that identifies chromosomal abnormalities including submicroscopic abnormalities that are too small to be detected by conventional karyotyping Like conventional fetal karyotyping prenatal chromosomal microarray analysis requires direct testin...

December 2013

PDF Format
212.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Number 659

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format
213.

Timing of Umbilical Cord Clamping After Birth

Number 543

(Reaffirmed 2014)

ABSTRACT The optimal timing for clamping the umbilical cord after birth has been a subject of controversy and debate Although many randomized controlled trials in term and preterm infants have evaluated the benefits of delayed umbilical cord clamping versus immediate umbilical cord clamping the id...

December 2012

PDF Format
214.

Tobacco Use and Women's Health

Number 503

(Reaffirmed 2015)

ABSTRACT Tobacco use negatively affects every organ system and is the most prevalent cause of premature death for adults within the United States Compared with women who are nonsmokers women who smoke cigarettes have greater risks of reproductive health problems many forms of gynecologic cancer an...

September 2011

PDF Format
215.

Tracking and Reminder Systems

Number 546

(Reaffirmed 2014, Replaces No. 461, August 2010)

ABSTRACT An accurate and effective tracking or reminder system is useful for the modern practice of obstetrics and gynecology Practices should not rely solely on the patient to complete all ordered studies and to follow up on health care provider recommendations Health care providers should encour...

December 2012

PDF Format
216.

Tubal Ligation with Cesarean Delivery

Number 205

Tubal ligation at the time of cesarean delivery requires significant additional physician work even though the technical work of the procedure is brief Informed consent by the patient requires considerably more counseling by the physician regarding potential risks and benefits of this procedure th...

August 1998

PDF Format
217.

Umbilical Cord Blood Banking

Number 648

(Replaces Committee Opinion Number 399, February 2008)

ABSTRACT Once considered a waste product that was discarded with the placenta umbilical cord blood is now known to contain potentially lifesaving hematopoietic stem cells When used in hematopoietic stem cell transplantation umbilical cord blood offers several distinct advantages over bone marrow o...

December 2015

PDF Format
218.

Understanding and Using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

(Reaffirmed 2014)

ABSTRACT The 2010 US Medical Eligibility Criteria for Contraceptive Use US MEC issued by the Centers for Disease Control and Prevention gives comprehensive evidencebased guidance to clinicians providing family planning services to women especially women with medical conditions The American College...

September 2011

PDF Format
219.

Understanding and Using the U.S. Selected Practice Recommendations for Contraceptive Use, 2013

Number 577

(Reaffirmed 2015)

ABSTRACT The US Selected Practice Recommendations for Contraceptive Use 2013 US SPR issued by the Centers for Disease Control and Prevention is a companion piece to the Centers for Disease Control and Preventions US Medical Eligibility Criteria for Contraceptive Use 2010 The US Medical Eligibility...

November 2013

PDF Format
220.

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998